FDA advisers recommend discontinuing 2 painkillers

02/1/2009 | CNNMoney

An FDA panel voted 14-12 in favor of withdrawing pain drugs Darvon and Darvocet from the U.S. market, citing efficacy concerns and safety risks. An official with Xanodyne Pharmaceuticals, which makes versions of both medicines, said the firm intends to meet with the FDA to discuss the decision "and come up with a plan on how to move forward."

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC